ResearchUtility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial
ResearchOlaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1/2 mutation: a multistudy analysis of response rates and safety
ResearchBreast Cancer Survivorship and Cardiovascular Disease: Emerging Approaches in Cardio-Oncology
ResearchEfficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy
ResearchNovel treatment strategies in triple-negative breast cancer: specific role of poly(adenosine diphosphate-ribose) polymerase inhibition
ResearchT2 magnetic resonance enables nanoparticle-mediated rapid detection of candidemia in whole blood
ResearchCediranib in combination with fulvestrant in hormone-sensitive metastatic breast cancer: a randomized Phase II study
ResearchChallenges to the development of new agents for molecularly defined patient subsets: lessons from BRCA1/2-associated breast cancer
ResearchOral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
ResearchOral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
ResearchLoss of C. elegans BBS-7 and BBS-8 protein function results in cilia defects and compromised intraflagellar transport